$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卵巢癌靶向药尼拉帕尼治疗效果明显吗?
2025-10-19 11:44:20
Check Details
尼拉帕尼多少钱一盒?
2025-10-19 11:44:20
Check Details
靶向药尼拉帕尼治疗卵巢癌的效果
2025-10-19 11:44:20
Check Details
卵巢癌用药尼拉帕尼安全性如何?
2025-10-19 11:44:20
Check Details
卵巢癌靶向药尼拉帕尼进入医保了吗?
2025-10-19 11:44:20
Check Details
卵巢癌治疗药物尼拉帕尼去哪买?
2025-10-19 11:44:20
Check Details
卵巢癌治疗用药尼拉帕尼说明书
2025-10-19 11:44:20
Check Details
卵巢癌用药尼拉帕尼(尼拉帕利)服用方法
2025-10-19 11:44:20
Check Details
研究发现辅助生殖技术不会增加患卵巢癌的风险
2025-10-19 11:44:20
Check Details
奥拉帕利吃一年要多少钱?
2025-10-19 11:44:20
Check Details
奥拉帕利靶向药的价格
2025-10-19 11:44:20
Check Details
晚期卵巢癌治疗新选择-奥拉帕利
2025-10-19 11:44:20
Check Details
1
2
...
860
861
862
863
864
865
866
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
2
Comprehensive Analysis of the Third-Generation EGFR-TKI
3
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
4
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
5
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
6
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
7
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
8
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
9
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
10
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
11
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
12
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features